Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel PDE IV inhibitors in the pipeline at Jouveinal/Parke-Davis

April 8, 1998

Novel steroids discovered at Inflazyme are particularly useful for asthma

April 7, 1998

Bayer prepares new compounds particularly useful for acute and chronic inflammation

April 7, 1998

Selective PDE IV/TNF-alpha inhibitors focus of research at Yamanouchi

April 6, 1998

Pfizer discovers compounds useful as cytokine and cell adhesion molecule inhibitors

April 3, 1998

SuperVent phase I/II trial going well; first part of two-part study concluded

April 3, 1998

Research at Pfizer leads to potent CysLT1 antagonist

April 2, 1998

Mochida prepares novel agents for disorders associated with eosinophilia

April 2, 1998

Moguisteine, a potential agent for treating allergic cough

March 31, 1998

Peptimmune and Peptide Therapeutics form asthma, autoimmune disease collaboration

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...